Winnergy Medical PCL (BKK:WINMED) ROCE %: 4.08% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:WINMED Winnergy Medical PCL BKK:WINMED
59 GF Score
Price ฿0.89
GF Value ฿1.86
Valuation Possible Value Trap
! 11 Warning Signs
View Full Analysis

What is Winnergy Medical PCL ROCE %?

Winnergy Medical PCL BKK:WINMED +1.14% 59 ROCE % is 4.08% as of Mar. 2026. GuruFocus rates BKK:WINMED with a GF Score™ of 59/100 and a GF Value™ of ฿1.86 (Possible Value Trap). The stock has 11 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Winnergy Medical PCL's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.08%.

Winnergy Medical PCL  (BKK:WINMED) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Winnergy Medical PCL ROCE % Related Terms

Winnergy Medical PCL ROCE % Historical Data

* Premium members only.

The historical data trend for Winnergy Medical PCL's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Winnergy Medical PCL ROCE % Chart

Winnergy Medical PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.49 11.74 6.44 6.13 4.38

Winnergy Medical PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.67 3.31 2.72 5.78 4.08
BKK:WINMED
59GF Score
Winnergy Medical PCL BKK:WINMED
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Winnergy Medical PCL ROCE % Calculation

Winnergy Medical PCL's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=34.979/( ( (1105.829 - 301.523) + (1131.871 - 337.15) )/ 2 )
=34.979/( (804.306+794.721)/ 2 )
=34.979/799.5135
=4.38 %

Winnergy Medical PCL's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=32.64/( ( (1131.871 - 337.15) + (1164.536 - 359.349) )/ 2 )
=32.64/( ( 794.721 + 805.187 )/ 2 )
=32.64/799.954
=4.08 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.08% mean?
Winnergy Medical PCL (BKK:WINMED) has a ROCE % of 4.08% as of Mar. 2026.
Is Winnergy Medical PCL's ROCE % too high?
Winnergy Medical PCL's current ROCE % is 4.08%. The Medical Distribution industry median ROCE % is 8.92. Winnergy Medical PCL's value of 4.08% is 54.3% below this industry median. Overall, Winnergy Medical PCL has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Winnergy Medical PCL's ROCE % compare to MCK and COR?
Winnergy Medical PCL's ROCE % of 4.08% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.92. Winnergy Medical PCL's value of 4.08% is 54.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 8.92, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Winnergy Medical PCL's current ROCE % of 4.08% is 54.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Winnergy Medical PCL's current ROCE % is 4.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Winnergy Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Winnergy Medical PCL (BKK:WINMED) is currently considered Possible Value Trap. The stock's GF Value™ is ฿1.86, compared to a current price of ฿0.89 — trading 52.2% below its estimated fair value. The current ROCE % is 4.08% and 54.3% below the Medical Distribution industry median of 8.92. Winnergy Medical PCL's overall GF Score™ is 59/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Winnergy Medical PCL (BKK:WINMED), the current ROCE % is 4.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Winnergy Medical PCL (BKK:WINMED) Overvalued in 2026?

Based on GuruFocus' analysis, Winnergy Medical PCL stock appears to be undervalued. The current stock price of ฿0.89 is trading 52.2% below its estimated GF Value™ of ฿1.86. GuruFocus considers Winnergy Medical PCL to be Possible Value Trap.

Key valuation signals for BKK:WINMED:

  • ROCE %: 4.08%
  • GF Value™: ฿1.86 vs. price of ฿0.89 (52.2% below fair value)
  • GF Score™: 59/100 with 11 warning signs
  • Industry Position: 54.3% below the Medical Distribution median

No single metric tells the full story. See the BKK:WINMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Winnergy Medical PCL Business Description

Address Pracha Uthit Road, No. 634/4 Soi Ramkhamhaeng 39 (Theplila 1), Wang Thong Lang Sub-District, Wang Thong Lang District, Bangkok, THA, 10310
Winnergy Medical PCL is engaged in the distribution of medical and diagnostics equipment. Its businesses include the distribution of medical devices, chemicals, and medical equipment and technology. The company operates in the geographic area of Thailand.
59GF Score

Get the complete analysis for BKK:WINMED

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.89
Price
฿1.86
GF Value